Semustine
- Generic Name
- Semustine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 13909-09-6
- Unique Ingredient Identifier
- 6YY7T1T567
- Indication
1.常用于脑部原发肿瘤（如成胶质细胞瘤）及继发肿瘤；
2.治疗实体瘤，如与氟尿嘧啶合用治疗为爱及直肠癌；
3.治疗霍奇金病。
- Associated Conditions
- -
- Associated Therapies
- -
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2021-06-30
- Target Recruit Count
- 100
- Registration Number
- NCT04945096
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- NSABP Foundation Inc
- Registration Number
- NCT00427570
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 151
- Registration Number
- NCT00335075
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath